AstraZeneca Tagrisso plus chemotherapy approved in EU for EGFR-mutated advanced lung cancer Ruchika Sharma8 July 2024 11:30 AM ISTCambridge: AstraZeneca has announced that Tagrisso (osimertinib) with the addition of pemetrexed and platinum-based chemotherapy has been...
Zydus Lifscience Gets CDSCO Panel Nod to Manufacture, Market Nivolumab for Metastatic Non-small Cell Lung Cancer Dr. Divya Colin7 July 2024 6:00 PM ISTNew Delhi: In a significant development, the drug major Zydus Life Sciences has got the go-ahead from the Subject Expert Committee (SEC) functional...
AstraZeneca Imfinzi fails in late-stage trial to treat type of lung cancer Ruchika Sharma30 Jun 2024 11:30 AM ISTCambridge: AstraZeneca has announced the high-level results from the ADJUVANT BR.31 Phase III trial, sponsored by the Canadian Cancer Trials...
USFDA issues complete response letter for Patritumab Deruxtecan in EGFR-Mutated NSCLC: Merck, Daiichi Sankyo Ruchika Sharma28 Jun 2024 10:00 AM ISTRahway: The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Biologics License Application (BLA)...
Hypoxemia due to sleep apnea associated with risk of lung cancer reoccurrence: Study Dr. Kamal Kant Kohli25 Jun 2024 8:00 PM ISTA new study to be presented at the SLEEP 2024 annual meeting is the first to find that episodic hypoxemia and hypoxic burden related to obstructive...
Early Menopause and Hormone Therapy may Impact Lung Health: Insights from PLCO Trial Analysis Medha Baranwal23 Jun 2024 8:45 PM ISTUSA: A secondary analysis of data from the PLCO Trial has revealed intriguing insights into the relationship between early menopause, hormone...
JnJ submits application to USFDA for Subcutaneous amivantamab for patients with EGFR-mutated non-small cell lung cancer Ruchika Sharma19 Jun 2024 3:56 PM ISTRaratin: Johnson & Johnson has announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration...
Bayer gets Breakthrough Therapy designation in China for lung cancer drug BAY 2927088 Ruchika Sharma15 Jun 2024 10:00 AM ISTBerlin: Bayer has announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) in China has...
AstraZeneca Tagrisso gets USFDA priority review for unresectable, Stage III EGFR-mutated lung cancer Ruchika Sharma11 Jun 2024 11:39 AM ISTAstraZeneca's supplemental New Drug Application (sNDA) for TAGRISSO (osimertinib) has been accepted and granted Priority Review in the US for the...
Roche Alecensa gets European Commission nod as targeted adjuvant treatment for ALK-positive early-stage lung cancer Ruchika Sharma10 Jun 2024 10:00 AM ISTBasel: Roche announced today that the European Commission has approved Alecensa (alectinib) monotherapy, as adjuvant treatment following tumour...
Low-fat diet associated with lower risk of lung cancer especially in smokers: Study Dr Riya Dave7 Jun 2024 9:00 PM ISTResearchers have found that adherence to a low-fat diet (LFD) can significantly reduce the risk of lung cancer in middle-aged and older adults. A...
AstraZeneca Tagrisso, chemotherapy recommended for approval in EU by CHMP for EGFR-mutated advanced lung cancer Ruchika Sharma5 Jun 2024 2:00 PM ISTCambridge: AstraZeneca's Tagrisso (osimertinib) with the addition of pemetrexed and platinum-based chemotherapy has been recommended for...
